← Home

Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial - The Next Web

2026-09-07

Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial - The Next Web

XLinkedInFacebook

Purple correction. Yellow abbreviation or name. Green phrase definition.

This text was inspired by the article↗Source — direct linkhttps://news.google.com/rss/articles/CBMie0FVX3lxTE5OcUxKNW83YTZocExBZmNpenBjdl9aZ1JMZDBUalpOa2FMZEhOV2t2eWp1NnF0MFpReWRtc19hTjRsY0dCcm9JOW5yX2tzZW10Zm9UYk03M1VtVmhpbEZ5SVdGMkFPZUtudnRkZktYRzVRVEY1RUxZRlZXWQ?oc=5

Insilico podaje, że lek na płuca zaprojektowany przez sztuczną inteligencję zmniejszył markery wieku biologicznego w badaniu z udziałem 42 pacjentów.

Article generated by artificial intelligence: Gemini by Google, Grok by xAI, Claude by Anthropic, ChatGPT by OpenAI.

office@freenetmedia.pl